🗳️ HFA Board & Nominating Committee elections 2026–2028 close today.
🗳️ This is your chance to shape the direction, priorities, and leadership of our community.
Take a minute & Make it count.
🗳️ Vote now: https://t.co/YSdUSlZzUy
@escardio #HFA_ESC @MarcoM@MarcoMetra@WilfriedMullens@jozinetm@GianluSava
Presented today at #ACC24:
In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: https://t.co/3625asvzu8
Last talking points this year. Presenting on-going research activities at the department.
First up, @ARuwald with the department’s participation in the nationwide DANABLATE-HF trial.
#dkforsk
Vil du høre eksperternes mening om ablation for atrieflimren? 🫀
Fredag d. 15/3 fra kl. 15-16 afholdes et virtuelt symposium med Professor @chris_sohns fra Bad Oeynhausen, Tyskland om ablation og CASTLE-HTX-studiet‼️
Tilmeld dig her: https://t.co/SPoBuvnth9
🗓️ Mark the calendars! 🗓️
Next weekend, we host our annual Weekend of Research as a celebration of our research activities!
Also, the topic of this year's discussion is atrial fibrillation with @chris_sohns, @Dominik_Linz, and @Jacob_M_Larsen as some of our guest speakers!
ARIES-HM3 Trial: In patients with HF receiving HM3 LVAD, VKA alone without aspirin results in no change in thrombotic outcomes, significantly less bleeding and less hospitalizations.
Download slides for the ARIES-HM3 trial on excluding aspirin in LVAD HM3 presented at #AHA23 Link here: https://t.co/1VAuUj8Wnz
Many relevant findings from PhD student @kasperbengtsen in his national study on risk factors associated with early and late S. aureus bacteraemia in CIED pts presented at #ESCCongress 🫀🧫
Congratulations on the hard work!👏👏
#ESC2023#DCS_ESC23
Danish data show higher CV risk in individuals with initial remission of #T2D than in those with well-controlled T2D on glucose-lowering therapy. This appeared related to lower CV RF management with statins and RASi. @AFalkentoft@ARuwald@Filip_Knop https://t.co/j5wPhLtNZX 🔓
The word “Pragmatic” is echoing throughout #HeartFailure2023 . This is a great development - we need more trials were the results are applicable in real-life HF population
@drjohnm@TorBiering@CardiologyZuh